Alectinib: Uses, Side Effects & Warnings

• Alectinib is primarily used for ALK-positive non-small cell lung cancer (NSCLC), offering a targeted approach to treatment.
• Common side effects include fatigue, constipation, and muscle pain, while serious side effects like liver problems and lung inflammation require immediate medical attention.
• Patients should be aware of important warnings, including potential for severe liver injury, kidney problems, and slow heart rate.
• Regular monitoring by a healthcare professional is essential throughout treatment to manage side effects and ensure safety.
• Adherence to the prescribed dosage and understanding of drug interactions are critical for effective therapy.

What is Alectinib for?

Alectinib is a prescription medicine used to treat non-small cell lung cancer (NSCLC) that is anaplastic lymphoma kinase (ALK)-positive. This means the cancer cells have a specific genetic mutation involving the ALK gene, which contributes to their growth and spread. As a kinase inhibitor, Alectinib works by blocking the activity of the ALK protein, thereby inhibiting the growth of cancer cells. It is often prescribed for patients whose cancer has spread to other parts of the body, or for those who have previously been treated with crizotinib but whose cancer has progressed.

The primary Alectinib uses focus on its efficacy in both first-line treatment and in patients who have developed resistance to other ALK inhibitors. Clinical trials have demonstrated significant improvements in progression-free survival for patients receiving Alectinib compared to chemotherapy or other targeted therapies in this specific patient population. For instance, a study published in the New England Journal of Medicine showed that Alectinib significantly prolonged progression-free survival in previously untreated ALK-positive NSCLC patients compared to crizotinib, with a median progression-free survival of 34.8 months versus 10.9 months, respectively. This highlights its critical role in modern oncology.

Understanding Alectinib drug information is crucial for both prescribers and patients. It is administered orally, typically as capsules taken twice daily with food. The precise dosage and duration of treatment depend on the individual patient’s condition, response to therapy, and the management of any side effects. Before starting treatment, patients undergo genetic testing to confirm the presence of the ALK mutation, ensuring that Alectinib is the appropriate and most effective treatment option for their specific type of lung cancer.

Alectinib Side Effects

Like all medications, Alectinib can cause side effects, ranging from mild to severe. It is important for patients to be aware of these potential effects and to report any new or worsening symptoms to their healthcare provider. Common Alectinib side effects often include fatigue, constipation, muscle pain (myalgia), swelling in the hands or feet (edema), and anemia. These are generally manageable but can impact quality of life if not addressed.

More serious side effects, though less common, can occur and require immediate medical attention. These include severe liver problems, lung inflammation (interstitial lung disease/pneumonitis), kidney problems, slow heart rate (bradycardia), and vision problems. Patients should be vigilant for symptoms such as yellowing of the skin or eyes, dark urine, severe stomach pain, new or worsening cough, shortness of breath, severe muscle weakness, or changes in vision. Regular monitoring of blood tests, including liver and kidney function, is typically performed throughout treatment to detect these issues early.

A comprehensive Alectinib medication guide provides detailed information on all known side effects, their frequency, and recommendations for management. Patients are encouraged to read this guide thoroughly and discuss any concerns with their doctor or pharmacist. It’s also vital to inform healthcare providers about all other medications, supplements, and herbal products being taken, as these can interact with Alectinib and potentially increase the risk or severity of side effects. Never adjust the dosage or stop taking Alectinib without consulting a healthcare professional.

Common Side Effects

Many patients experience mild to moderate side effects that can often be managed with supportive care. These effects typically subside as the body adjusts to the medication or with dose modifications.

• Fatigue or weakness
• Constipation
• Muscle pain (myalgia)
• Swelling in hands, feet, or ankles (edema)
• Anemia (low red blood cell count)
• Rash
• Nausea or vomiting
• Diarrhea
• Changes in taste

Serious Side Effects Requiring Medical Attention

While less frequent, some side effects of Alectinib can be severe and necessitate prompt medical intervention. Recognizing these symptoms early is crucial for patient safety and effective management.

• Liver Problems: Symptoms include yellowing of the skin or eyes (jaundice), dark urine, nausea, vomiting, severe stomach pain, or unusual tiredness.
• Lung Problems (Pneumonitis): New or worsening cough, shortness of breath, or fever.
• Kidney Problems: Changes in the amount of urine, swelling in the legs or feet, or unusual tiredness.
• Slow Heart Rate (Bradycardia): Feeling dizzy, lightheaded, or fainting.
• Muscle Pain, Tenderness, or Weakness: Especially if accompanied by dark urine, which could indicate rhabdomyolysis.
• Vision Problems: Any new or worsening vision changes.

Important Alectinib Warnings and Patient Information

Patients prescribed Alectinib must be fully informed about critical warnings and specific patient information to ensure safe and effective treatment. One of the most significant Alectinib warnings pertains to potential liver toxicity. Patients should undergo regular liver function tests before and during treatment, and any signs of liver injury, such as jaundice or severe abdominal pain, must be reported immediately. The U.S. Food and Drug Administration (FDA) advises close monitoring for these adverse events.

Other vital warnings include the risk of severe lung inflammation (interstitial lung disease/pneumonitis), which can be life-threatening. Patients experiencing new or worsening respiratory symptoms like cough, shortness of breath, or fever should seek urgent medical evaluation. Additionally, Alectinib can cause kidney problems, muscle pain (myalgia) that can be severe, and a slow heart rate (bradycardia). Regular monitoring of kidney function, creatine phosphokinase (CPK) levels for muscle issues, and heart rate is often part of the treatment protocol.

Comprehensive Alectinib patient information also covers drug interactions, pregnancy, and breastfeeding. Alectinib can interact with other medications, including certain antifungals, antibiotics, and herbal supplements like St. John’s Wort, potentially altering its effectiveness or increasing side effects. Women of childbearing potential should use effective contraception during treatment and for at least one week after the last dose, as Alectinib can harm an unborn baby. Breastfeeding is not recommended during treatment and for at least one week after the last dose due to the potential for serious adverse reactions in a breastfed infant. Always discuss these crucial details with your healthcare provider to ensure a safe and effective treatment plan.

Frequently Asked Questions

What type of cancer does Alectinib treat?

Alectinib is specifically approved for treating non-small cell lung cancer (NSCLC) that tests positive for the anaplastic lymphoma kinase (ALK) gene mutation. This targeted therapy works by blocking the activity of the ALK protein, which is responsible for driving cancer cell growth in these specific tumors. It can be used as a first-line treatment or for patients whose cancer has progressed after prior treatment with other ALK inhibitors, offering a precise approach to managing this particular subtype of lung cancer.

What should I do if I miss a dose of Alectinib?

If you miss a dose of Alectinib, take it as soon as you remember, unless it is less than 6 hours before your next scheduled dose. In that case, skip the missed dose and continue with your regular dosing schedule. Do not take two doses at the same time to make up for a missed dose. It’s crucial to maintain a consistent dosing schedule for optimal effectiveness. If you vomit after taking a dose, do not take an additional dose; simply take your next dose at the regularly scheduled time.

Are there any dietary restrictions while taking Alectinib?

While there are no strict dietary restrictions, Alectinib should be taken with food to help with absorption and potentially reduce gastrointestinal side effects. It’s generally recommended to avoid grapefruit and grapefruit juice, as they can interact with the medication and potentially increase its levels in the body, leading to a higher risk of side effects. Always consult your healthcare provider or pharmacist for personalized dietary advice and to review any potential food or supplement interactions with Alectinib.